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In this work, novel metallophthalocyanine compounds (M¼ Zn, Cu, Co) bearing four 2-methoxy-4-{(Z)-
[(4-morpholin-4-ylphenyl)imino]methyl}phenol at the peripheral positions were sythesized starting
from the new phthalonitrile derivative (2). These new compounds (2e5) have been characterized by a
combination of FT-IR, 1H NMR (for compounds 2 and 3), 13C NMR (for compound 2), UVeVis (for com-
pounds 3,4 and 5) and mass spectrophotometry techniques. Antioxidant activities of the metal-
lophthalocyanines were investigated by using DPPH free radical scavenging assay and FRAP (ferric ion
reducing antioxidant power) method. The antimicrobial activity of the synthesized metallo phthalocy-
anine compounds (3e5) were determined against the selected different six standart bacteria isolates by
microdilution broth assay with Alamar Blue Dye. Most affected bacteria from the compounds were
standard E. coli and S. typhimurium (MIC 625 mg/ml). Standart Y. enterocolitica and S. aureus have been less
affected by the compounds (MIC 10.000 mg/ml).
© 2019 Published by Elsevier B.V.1. Introduction
Phthalocyanine compounds (Pcs) are heterocyclic compounds
with thermal, chemical and photo-stability, chemical inertness and
long wavelength absorption compatible with biological window.
There are widely potential applications in technology andmedicine
owing to their physicochemical properties [1]. They have been used
different application areas such as solar cell, dyes and pigments,
catalysis, sensors, non-linear optical materials (NLO) and photo-
dynamic therapy (PDT) [2e9]. The most interesting ones are
peripherally substituted phthalocyanines bearing different metal
cations into the macrocyclic core [10,11]. Phthalocyanines have to
be soluble and pure in order to be used in these applications. In this
regard, an important goal of Pc chemistry is to synthesize soluble
Pcs.41.
u.tr, ayse_aktas_kamiloglu@According to the recent literature data, the scientific in-
vestigations related to the synthesis, conversions, and research of
physiologically active substances with different application areas
have been expanded [12]. Especially taking into account that the
Schiff base, pyrimidine-thiones, natural or synthetic phenol com-
pounds, morpholine are compounds with great pharmacological
activity, the development of optimal synthesis method of these
compounds are always in the spotlight of the researchers [13e15].
Novel and efficient methods for synthesis of phthalocyanines
are an active area of research in industry and academia due to their
applications in biological tests [16e20]. Many morpholine and its
derivatives are important compounds with pharmacological and
biological properties such as anticancer [21], tyrosinase inhibitory
activities [22], antioxidant [23], antimicrobial [24,25], anti-
inflammatory [26] and photodynamic therapy [27]. Furthermore,
the most considerable properties of Schiff base exhibit antibacte-
rial, antifungal and anticancer activities to have been submitted in
the literature [28e30]. In addition to this Schiff bases containing
morpholine have good antioxidant and antimicrobial activities [31].
For many years, antimicrobial activities, antibacterial and
D. Unluer et al. / Journal of Organometallic Chemistry 900 (2019) 1209362antifungal properties of compounds have been tried to determine.
The Alamar Blue (resazurin) dye has been shown to provide a useful
for investigation proliferation and cytotoxicity in lymphocytes and
other cell lines. The Alamar Blue Dye for detection of metabolic
activity works as a fluorometric/colorimetric growth indicator [32].
Alamar Blue Dye which non-toxic for cell even during long incu-
bation times is an oxidation reduction indicator that changes colour
from blue to pink in the presence of bacterial or fungal viability as a
response to chemical reduction of the growth medium [33].
Recently, researchers have also researched the antioxidant and
antimicrobial activities of Pc compounds [34e40]. The antimicro-
bial and antioxidant properties of phthalocyanine molecules vary
according to the metal ion type and the types of substituted groups
[41e46]. So, we purposed to determine the antibacterial activity by
the microdilution broth assay with Alamar Blue Assay method in
synthesized Pcs compounds.
In this study, new phthalonitrile derivative (2) and metal-
lophthalocyanine complexes (3, 4 and 5) having morpholine moi-
ety on their peripheral position were synthesized. The
characterization of the novel compounds (2e5) were done by
various spectroscopic techniques such as, FT-IR, NMR, UVeVis and
mass spectrometry. The antioxidant and antimicrobial properties of
phthalocyanine compounds (3e5) were investigated.
2. Experimental
2.1. Materials and equipment
The used materials, antioxidant and antimicrobial procedure
and equipments were supplied as supplementary information.
2.2. Synthesis of the compounds 2,3,4,5
2.2.1. Synthesis of 4-(2-metoxy-4-{(E)-[(4-morpholin-4-ylphenyl)
imino]methyl}phenoxy) phthalonitrile (2)
Schiff base compound (1) was prepared according to literature
[24]. 4-(2-methoxy-4-{(E)-[(4-morpholin-4-ylphenyl)imino]
methyl}phenol (1) (2.0 g, 6.41mmol) and 4-nitrophthalonitrile
(1.11 g, 6.41mmol) were dissolved in dry DMF (dimethylforma-
mide) (20ml) and the solutionwas stirred at 60 C. Then, dry K2CO3
(2.65 g, 19.20mmol) was added into this solution the portion wise
during 2 h. The system was stirred under N2 at same temperature
for 5 days. After this time, the reactionmixturewas poured into ice-
water and stirred at room temperature. The mixture was filtered
and dried in vacuum over P2O5. The obtained yellow crude product
was purified using column chromatography with silicon dioxide as
the column material and a chloroform/ethanol (10:2) solvent sys-
tem. Yield: 1.6 g (57%), mp: 197e200 C. IR (ATR), nmax/cm1: 3079
(ArH), 2969e2858 (Aliph. CeH), 2231 (C^N), 1625e1591 (C]C),
1508e1487 (CH]N), 1414, 1319, 1240, 1116, 1033, 927, 860, 823,
723, 618, 582. 1H NMR. (400MHz, CDCl3), (d:ppm): 8.68 (s, 1H,
CeH), 8.07e8.05 (d, 1H, ArH), 7.77e7.73 (d, 2H, ArH), 7.57e7.55
(d,1H, ArH), 7.35e7.28 (m, 4H, ArH and CDCl3), 7.01e6.99 (d, 2H,
ArH), 6.99e6.49 (dd, 1H, ArH), 3.82 (s, 3H, OeCH3), 3.75 (s, 4H,
OeCH2), 3.34 (s, 4H, NeCH2). 13C NMR. (400MHz, CDCl3), (d:ppm):
161.45, 156.54, 151.72, 143.56, 142.76, 136.62, 136.22, 123.04, 123.00,
122.66, 121.80, 121.13, 118.05, 117.02, 116.40, 115.89, 115.23 (C^N),
112.29 (C^N), 108.33, 66.53 (OeCH2), 56.33 (OeCH3), 48.84
(NeCH2). MALDI-TOF-MS, (m/z): Calculated: 438.84; Found: 438.65
[M]þ.
2.2.2. Synthesis of Zinc(II) phthalocyanine (3)
Phthalonitrile compound (2) (0.3 g, 0.68 103mol),
Zn(CH3COO)2 (0.044 g, 0.36 103mol) and 1.8-diazabicyclo[5.4.0]
undec-7-ene (DBU) (10 drops) in 3ml of dry n-pentanol werestirred at 160 C in a sealed glass tube for 24 h under N2(g). After
cooling to room temperature, the solution was poured in ethanol.
Green precipitate was filtered off. The obtained green product was
purified by column chromatography on silicon oxide by using
CHCl3:CH3OH as solvent system. Yield: 99mg (32%). mp: >300 C.
IR (ATR) nmax/cm1: 3070 (ArH), 2955e2852 (Aliph. CeH),
1617e1597 (C]N), 1506e1449 (C]C), 1260, 1115, 1087, 1030, 924,
821, 743. 1H NMR. (400MHz, CDCl3), (d:ppm): 8.68 (s, 4H, CeH),
7.40e7.28 (m, 20H, ArH), 7.02 (s, 16H, ArH), 6.65e6.53 (m, 4H,
ArH), 3.76 (s, 12H, OeCH3), 3.35 (s, 16H, OeCH2), 3.15 (s, 16H,
NeCH2). UVeVis (DMF): lmax, nm (log ε): 681 (4.98), 612 (4.34), 362
(4.89). MALDI-TOF-MS, (m/z): Calculated: 1819.30; Found:1819.62
[M]þ.
2.2.3. Synthesis of copper (II) phthalocyanine (4)
4-(2-methoxy-4-{(E)-[(4-morpholin-4-ylphenyl)imino]methyl}
phenoxy) phthalocyaninato copper (II) (4) was synthesized simi-
larly to (3) by using anhydrous CuCl2 instead of anhydrous Zn(ac)2.
Yield: 100mg (32%). mp: > 300 C. IR (ATR) nmax/cm1:
3070(ArH), 2958e2853 (Aliph. CeH), 1618e1595 (C]N),
1505e1449 (C]C), 1260, 1219, 1115, 1093, 1029, 924, 822, 744.
UVeVis (DMF): lmax, nm (log ε): 679 (4.88), 616 (4.58), 376 (5.19).
MALDI-TOF-MS, (m/z): Calculated: 1817.47; Found: 1817.91 [M]þ.
2.2.4. Synthesis of cobalt (II) phthalocyanine (5)
4-(2-methoxy-4-{(E)-[(4-morpholin-4-ylphenyl)imino]methyl}
phenoxy) phthalocyaninato cobat (II) (5) was synthesized similarly
to (3) by using anhydrous CoCl2 instead of anhydrous Zn(ac)2. Yield:
79mg (26%). mp: > 300 C. IR (ATR) nmax/cm1: 3068 (ArH),
2954e2853 (Aliph. CeH), 1619, 1595 (C]N), 1506e1449 (C]
C),1413, 1260, 1217, 1114, 1095, 923, 822, 749. UVeVis (DMF): lmax,
nm (log ε): 666 (4.86), 608 (4.47), 364 (5.14). MALDI-TOF-MS, (m/z):
Calculated: 1812.85; Found: 1812.03 [M]þ.
3. Results and discussion
3.1. Synthesis and characterization
The synthetic pathway for the synthesis of phthalonitrile com-
pound (2), Zn(II) (3), Cu(II) (4) and Co(II) (5) phthalocyanine com-
plexes was shown in Fig. 1. The synthesis of phthalonitrile
compound (2) was achieved by aromatic displacement of 2-
methoxy-4-{(Z)-[(4-morpholin-4-ylphenyl)imino]methyl}phenol
(1) with 4-nitrophthalonitrile in the presence of K2CO3 in dry DMF.
The new vibration appeared at 2231 cm1 (C^N) verified the for-
mation. The formation of compound (2) was confirmed by the
combination of spectroscopic data. In the IR spectra of compound
(2), the peak due to phenolic OeH vibration of compound (1) dis-
appeared. The new vibration (C^N) appeared at 2231 cm1 veri-
fied the formation of compound (2). In the 1H NMR spectra of (2),
the phenolic OH signals of compound (1) disappeared and showed
new aromatic protons signals. The characteristic new signals of
carbon atom belonging to at 115.23 (C^N) and 112.29 (C^N) ppm
in 13C NMR spectra, supported the structure. The molecular ion
peak of compound (2)was observed atm/z: 438.65 [M]þ, confirmed
the proposed chemical structure.
The peripherally tetra-substituted Zn(II), Cu(II) and Co(II)
phthalocyanines were accomplished in the presence of metal salts
(Zn(CH3COO)2, CuCl2 and CoCl2) and DBU at 160 C in n-pentanol in
24 h by cyclotetramerization of compound (2). These novel
phthalocyanine derivatives were purified by column chromatog-
raphy. The obtained phthalocyanines (3e5) are soluble in general
organic solvents such as THF (Tetrahydrofuran), CHCl3 (chloforom),
DMF, CH2Cl2 (dichloromethane) and DMSO. The formation of Pc
compounds (3e5) were clearly confirmed by the disappearance of
Fig. 1. The synthesis route of compounds 2e5.
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phthalocyanine (3) was similar with phthalonitrile compound (2).
This similarity is another evidence of the formation of wanted
compounds. In the MALDI-TOF mass spectrum of compound (3)
showed a peak at m/z¼ 1819.62 [M]þ, confirmed the proposedformula (Fig. 2). The NMRmeasurements of complexes copper(II)Pc
(4) and cobalt(II)Pc (5) could not be obtained due to the para-
magnetic nature [47]. Their molecular ion peaks at m/z¼ 1817.91
[M]þ (Fig. 3) and 1812.03 [M]þ respectively in mass spectra, are in
accordance with the expected values.
Fig. 2. MALDI-TOF-MS spectrum of ZnPc; b) MALDI-TOF-MS spectrum of CuPc.
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The UVeVis spectra of the phthalocyanines show two strong
absorption regions. One is B bands at 300e500 nm in the UV region.
The other is Q band at near 600e700 nmwhich is more intense and
energetic absorption [48]. Fig. 2 shows UVeVis absorption spec-
trum of the metallophthalocyanine (3e5) in DMF at
1 105mol dm3 concentration. In the UVeVis absorption
spectra of (3), (4) and (5) intense Q band absorptions were observed
at 681, 679 and 666 nm, respectively, while the B band absorptions
were observed at 362, 376 and 364 nm, respectively. Metal-
lophthalocyanines belonging to D4h symmetry exhibits only an
intense Q band absorption in their UVeVis spectra [49].
Metallophthalocyanines (3), (4) and (5) have the same periph-
erally group, but have different metal center. This similarity inmolecular structure resulted in similar shaped Q bands with small
shifts in the wavelength (Fig. 4). The Q band positions of metal-
lophthalocyanines (3e5) were observed in the order of
ZnPc> CuPc> CoPc.3.3. Antioxidant activity
In this study, FRAP and DPPH tests were followed to evaluate the
antioxidant activities of three compounds (Co, Cu and Zn) and the
results are presented in Fig. 5 [50e53]. In the FRAP and DPPH tests,
the increasing FeSO4$7H2O equivalent and the decreasing SC50
value are indicative of more effective activity. When the results
were compared with the results obtained from the standard anti-
oxidant compound (Trolox), it was determined that the activities
obtained from compound CoPc (5) and ZnPc (3) were quite high
Fig. 3. 1H NMR spectrum of phthalonitrile compound 2.
Fig. 4. UVeVis absorption spectrum of ZnPc, CoPc and CuPc in DMF at 1 105M.
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reducing power test, the FRAP values were defined as 5948.3,
3084.4 and 4709.4 mM FeSO4$7H2O equivalent/g sample. The
highest FRAP value (i.e. the highest activity) and the lowest FRAP
value (i.e. lowest activity) was measured in compound CoPc and
CuPc, respectively. In the DPPH assay, the compounds have a sig-
nificant free radical scavenging effect (against the DPPH radical)with SC50 values of 23.31, 63.15 and 23.52 mg/mL. The strongest
activity was observed in compound CoPc (5) (SC50: 23.31 mg/mL)
and the weakest activity in compound CuPc (4) (SC50: 63.15 mg/mL).
The SC50 value of standard antioxidant compound (trolox) was
found as 5.11 mg/mL. The lower IC50 means higher antioxidant po-
wer [54]. According to this, the descending order of IC50 values of
phthalocyanine compounds was 4> 3> 5.
Fig. 5. Ferric reducing antioxidant power (FRAP), and radical scavenging activities (DPPH) of phthalocyanine compounds (3e5).
D. Unluer et al. / Journal of Organometallic Chemistry 900 (2019) 1209366The connected substituent on Pc and centrally located metal
atom effect antioxidant activity [54,55]. The increase in redox ac-
tivity of the central metal atom in the phthalocyanine compounds
also increases the antioxidant property. According to the DPPH and
FRAP tests, the order of the antioxidant effect of Pc compounds was
CoPc (5)> ZnPc (3)> CuPc (4). These results showed a higher
antioxidant effect compared with Pcs in the literature [56].Fig. 6. Antibacterial activity shown in microplate of the compound CoPc (5).3.4. Antimicrobial activity
The antibacterial activity of the synthesized Pc compounds were
screened against Gram positive strains (S. aureus [MRSA]), Gram
negative strains (E. coli, S.typhimurium, Y. enterocolitica, S.flexneri) and
Gram negative nonfermenter strain (P. aeruginosa). MIC interpreta-
tion criteria of standard bacteria isolates against standard amikacin
antibiotic were made according to the CLSI (Clinical and Laboratory
Standards Institute, CLSI M100-S25) [57]. MIC values of the com-
pounds were given in Table 1. Antibacterial activities assessed with
Alamar Blue Dye were shown in Fig. 6. In the study were assessed
negative control in 7thwells and positive control in 8thwells (Fig. 6).
The highest antibacterial activity were observed for E.coli and
S.typhimurium (minimum inhibitory concentrations (MIC) 625 mg/Table 1
The antibacterial activities of five compounds against bacterial isolates (MIC value mg/m
Complexes Bacteria
Escherichia coli Salmonella typhimurium Shigella flexneri Yer
CoIIPc 625 625 1.250 10.
CuIIPc 625 625 5.000 10.
ZnIIPc 1.250 1.250 2.500 >10mL). All negative and positive controls were working properly.
CoPc (5) was found to have antimicrobial activity at different
concentrations against all standard bacteria. In vitro studies have
showed that the especially compounds CoPc (5) and CuPc (4) have
remarkable antibacterial activity for S. typhimurium, and E. Coli
(Table 1). Therefore, this study can contribute to new drug devel-
opment on based the compound.l).
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The phthalonitrile derivative (2), Zn(II), Cu(II) and Co(II)
phthalocyanine compounds (3e5) which are substituted with
morpholine bearing schiff base group have been synthesized for
the firstly. All compounds were characterized by different spec-
troscopic method for the secondly. These synthesized phthalocya-
nine complexes (3e5) exhibit high solubility in common organic
solvents owing to the addition of 4-(2-methoxy-4-{(E)-[(4-
morpholin-4-ylphenyl)imino]methyl}phenol groups on the struc-
ture. Antioxidant activities were determined by using, FRAP (ferric
reducing antioxidant power) and DPPH free radical scavenging
systems. In all antioxidant assays, CoPc (5) showed higher activities
than other Pcs (3 and 4). The order of the antioxidant activity was
CoPc> ZnPc> CuPc. Finally antimicrobial activities of metallo Pcs
were determined usingmicrodilution broth assay with Alamar Blue
Dye. According to in vitro studies, especially compounds CoPc (5)
and CuPc (4) have remarkable antibacterial activity for
S. typhimurium, and E. coli. Therefore, this work can contribute to
new drug development on based the compound. Besides, due to
these encouraging in vitro antimicrobial activity results, after
further studies, the compound can be evaluated as new therapeutic
agent against for the bacteria.
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